Published on Global Research Projects (https://globalprojects.ucsf.edu)

Home > Phase 1 Open-Label First-in-Human Dose-Escalating Safety and Tolerability Study Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients With Advanced Unresectable Malignancies That Are Refractory to All Standard

Phase 1 Open-Label First-in-Human Dose-Escalating Safety and Tolerability Study Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients With Advanced Unresectable Malignancies That Are Refractory to All Standard

© 2019 The Regents of the University of California
Source URL: https://globalprojects.ucsf.edu/project/phase-1-open-label-first-human-dose-escalating-safety-and-tolerability-study-evaluating